InvestorsHub Logo

Amatuer17

04/06/18 11:12 AM

#3670 RE: harry crumb #3669

https://www.investors.com/news/technology/incyte-plunges-20-after-key-melanoma-combination-with-merck-fails/

This was a combo therapy with Ketruda - PD-1

TINIVO falls in same category - so all companies with combo therapies with PD-1 drugs